CircMYOF acts as a miR-4739 sponge to promote progression and facilitate glycolysis via VEGFA/PI3K/AKT pathway in pancreatic ductal adenocarcinoma.

被引：0
|
作者：
Zheng, Dandan [1 ]
Huang, Xianxian [2 ]
Peng, Juanfei [1 ]
Zhuang, Yanyan [1 ]
Li, Yuanhua [3 ]
Qu, Junchi [1 ]
Zhang, Shineng [1 ]
Huang, Fengting [1 ]
机构：
[1] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 8, Shenzhen, Peoples R China
[3] Sun Yat Sen Univ, Tungwah Hosp, Dongguan, Peoples R China
来源：
CANCER RESEARCH | 2021年 / 81卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-026
引用
收藏
页码：20 / 20
页数：1
相关论文
共 50 条
  • [21] Bmi1 is required for pancreatic ductal adenocarcinoma formation through regulating PI3K/AKT pathway and acinar genes
    Sono, Makoto
    Fukuda, Akihisa
    Masuda, Tomonori
    Fukunaga, Yuichi
    Yoshikawa, Takaaki
    Araki, Osamu
    Nagao, Munemasa
    Hiramatsu, Yukiko
    Ogawa, Satoshi
    Tsuda, Motoyuki
    Maruno, Takahisa
    Nakanishi, Yuki
    Seno, Hiroshi
    CANCER SCIENCE, 2022, 113 : 566 - 566
  • [22] MiR-19 enhances pancreatic cancer progression by targeting PTEN through PI3K/AKT signaling pathway
    Zhang, G-F
    Zhong, J-M
    Lin, L.
    Liu, Z-H
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (03) : 1098 - 1107
  • [23] HIF-1α-regulated stanniocalcin-1 mediates gemcitabine resistance in pancreatic ductal adenocarcinoma via PI3K/AKT signaling pathway
    Zhao, Fangyu
    Yang, Gang
    Qiu, Jiangdong
    Liu, Yueze
    Tao, Jinxin
    Chen, Guangyu
    Su, Dan
    You, Lei
    Zheng, Lianfang
    Zhang, Taiping
    Zhao, Yupei
    MOLECULAR CARCINOGENESIS, 2022, 61 (09) : 839 - 850
  • [24] SPDEF drives pancreatic adenocarcinoma progression via transcriptional upregulation of S100A16 and activation of the PI3K/AKT signaling pathway
    Jiang, Hang
    Xue, Zhiqian
    Zhao, Liping
    Wang, Boyuan
    Wang, Chenfei
    Song, Haihan
    Sun, Jianjun
    BIOMOLECULES AND BIOMEDICINE, 2024, 24 (05): : 1231 - 1243
  • [25] Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway
    Liang, Jinghui
    Li, Haixia
    Han, Jingyi
    Jiang, Jin
    Wang, Jiang
    Li, Yongmeng
    Feng, Zitong
    Zhao, Renchang
    Sun, Zhenguo
    Lv, Bin
    Tian, Hui
    CELL DEATH & DISEASE, 2020, 11 (08)
  • [26] Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway
    Jinghui Liang
    Haixia Li
    Jingyi Han
    Jin Jiang
    Jiang Wang
    Yongmeng Li
    Zitong Feng
    Renchang Zhao
    Zhenguo Sun
    Bin Lv
    Hui Tian
    Cell Death & Disease, 11
  • [27] CaMKKβ regulates proliferation, apoptosis, and glycolysis of hepatocellular carcinoma via PI3K/AKT pathway
    Sheng, Tao
    Mao, Xing-Bo
    Zhang, Shao-Hua
    ANNALS OF PALLIATIVE MEDICINE, 2020, 9 (06) : 3857 - 3869
  • [28] AURKB targets DHX9 to promote hepatocellular carcinoma progression via PI3K/AKT/mTOR pathway
    Zhu, Guoqing
    Luo, Laihui
    He, Yongzhu
    Xiao, Yongqiang
    Cai, Ziwei
    Tong, Weilai
    Deng, Wei
    Xie, Jin
    Zhong, Yanxin
    Hu, Zhigao
    Shan, Renfeng
    MOLECULAR CARCINOGENESIS, 2024, 63 (09) : 1814 - 1826
  • [29] LncUBE2R2-AS1 acts as a microRNA sponge of miR-302b to promote HCC progression via activation EGFR-PI3K-AKT signaling pathway
    Wu, Zhe
    Wei, Zhi-Hong
    Chen, Shao-Hua
    CELL CYCLE, 2020, 19 (19) : 2426 - 2435
  • [30] miR-320/ELF3 axis inhibits the progression of breast cancer via the PI3K/AKT pathway
    Zhang, Zhiqiang
    Zhang, Jinku
    Li, Jinmei
    Geng, Huijuan
    Zhou, Bingjuan
    Zhang, Bingxin
    Chen, Hong
    ONCOLOGY LETTERS, 2020, 19 (04) : 3239 - 3248
12345